Internal Medicine, Endocrinology, Diabetes, & Metabolism · Winston Salem, NC
NPI
1740627496
Since 2013
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
755 Highland Oaks Dr Ste 201
Winston Salem, NC, 27103
Phone (336) 765-0020
Groups this clinician bills Medicare through
Medicare paid, 2024
$42K
1,105 services
Medicare patients, 2024
273
Average age 72
Drug cost, 2024
$1.9M
4,102 prescriptions
Company payments, 2024
$145
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark V Guido was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 406 times for 244 patients. In total Mark V Guido billed 1,105 services in 11 codes, and Medicare paid $42K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-10-26.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 406 | 244 | $11.02 | $4,473 |
| 99214 Office E&M - Established | Office | 386 | 199 | $64.59 | $25K |
| 95251 Test - Miscellaneous | Office | 170 | 58 | $24.38 | $4,145 |
| 99213 Office E&M - Established | Office | 54 | 50 | $41.25 | $2,228 |
| 99204 Office E&M - New | Office | 43 | 43 | $87.03 | $3,742 |
| 76536 Ultrasound - Nonspecific | Office | 17 | 17 | $19.95 | $339 |
| 99215 Office E&M - Established | Office | 17 | 17 | $94.72 | $1,610 |
By year: 2022 $32K for 500 services; 2023 $33K for 536 services; 2024 $42K for 1,105 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mark V Guido prescribed most often to Medicare patients was Levothyroxine Sodium, with 536 prescriptions and refills. In total Mark V Guido wrote 4,102 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 536 | 1,315 | 132 | $5,659 |
| Mounjaro Tirzepatide | 274 | 352 | 55 | $376K |
| Metformin Hcl Er Metformin Hcl | 222 | 607 | 76 | $2,856 |
| Ozempic Semaglutide | 189 | 298 | 41 | $283K |
| Methimazole Generic | 174 | 422 | 49 | $1,375 |
| Tresiba Flextouch U-100 Insulin Degludec | 153 | 357 | 51 | $88K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 141 | 366 | 59 | $15K |
| Rosuvastatin Calcium Generic | 120 | 284 | 28 | $1,010 |
| Synthroid Levothyroxine Sodium | 119 | 230 | 27 | $9,795 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 114 | 264 | 37 | $13K |
| Glipizide Er Glipizide | 99 | 285 | 35 | $2,256 |
| Humulin R U-500 Kwikpen Insulin Regular, Human | 98 | 130 | 15 | $163K |
| Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 | 95 | 193 | 20 | $122K |
| Pioglitazone Hcl Generic | 93 | 236 | 26 | $1,247 |
| Jardiance Empagliflozin | 88 | 156 | 18 | $90K |
Brand drugs: 2,110 claims; generic drugs: 1,610 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Mark V Guido $145 ($145 in general payments such as food, travel and fees) from 1 company. The largest payer was Novo Nordisk Inc with $145.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 4 | $145 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.